Uso de alteplase no tratamento do acidente vascular encefálico isquêmico agudo: o que sabem os enfermeiros?
Maniva, Samia Jardelle Costa de Freitas; Freitas, Consuelo Helena Aires de.
Rev. bras. enferm
; 65(3): 474-481, maio-jun. 2012.
Artigo em Português | LILACS, BDENF | ID: lil-650641
Documentos relacionados
Reasons and predictors of non-thrombolysis in patients with acute ischemic stroke admitted within 4.5 h.
Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke.
Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis.
Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice.
Tenecteplase in Acute Stroke: What About the Children?
Molecular Hydrogen: Emerging Treatment for Stroke Management.
Tenecteplase Improves Reperfusion across Time in Large Vessel Stroke.
Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society.
The role of stroke nurses in thrombolysis administration in Australia and the United Kingdom: A cross-sectional survey of current practice.
The use of recombinant tissue plasminogen activator in in acute ischemic stroke is associated with increased level of BDNF.